tirzepatide vs semaglutide en español vs. for weight loss compared What Are the Side Effects

The muscle-preserving effects become particularly valuable as you progress through your weight loss journey, ensuring that the weight you lose comes primarily from fat stores rather than valuable lean tissue

Ambery PD, Klammt S, Posch MG et al (2018) MEDI0382, a GLP-1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single-dose, healthy-subjects, randomized, phase 1 study

Fase-2-obesitasstudie (NEJM, 2023): bij volwassenen met obesitas/overgewicht leidde retatrutide tot gemiddeld ~17,5% gewichtsverlies op 24 weken en tot ~24% op 48 weken (secundaire uitkomst)

Calibrate expectations